Moxetumomab pasudotox-tdfk Intravenous and Ritonavir Powder Packets
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Ritonavir Powder Packets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: ritonavir
Brand name: Norvir, Norvir Soft Gelatin
Synonyms: Ritonavir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Ritonavir Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Rituxan
- Moxetumomab pasudotox-tdfk Intravenous-Rituxan Hycela
- Moxetumomab pasudotox-tdfk Intravenous-Rituximab
- Moxetumomab pasudotox-tdfk Intravenous-Rituximab and Hyaluronidase
- Moxetumomab pasudotox-tdfk Intravenous-Rituximab and hyaluronidase human, recombinant Subcutaneous
- Ritonavir Powder Packets-Moxifloxacin
- Ritonavir Powder Packets-Moxifloxacin (Systemic)
- Ritonavir Powder Packets-Moxifloxacin Hydrochloride
- Ritonavir Powder Packets-Moxifloxacin Injection
- Ritonavir Powder Packets-Moxifloxacin Intravenous
- Ritonavir Powder Packets-Moxifloxacin Tablets